Big Gain For Lineage Cell Therapeutics, Inc.

Tue, Apr 06, 2021 at 05:30 PM
Big Gain For Lineage Cell Therapeutics, Inc.

Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT) shot up at $6.07, representing a gain of 30%. The stock appeared on our News Catalysts scanner on Thu, Apr 01, 2021 at 09:59 AM in the 'MERGER' category. From Mon, Mar 22, 2021, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Tue, Mar 16, 2021 at $10.28 with a volume of 3M+.

About Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT)

BioTime Inc focuses regenerative medicine technologies in ophthalmology, soft tissue reconstruction, and the local delivery of cells and therapeutics.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
Your price will remain at $9.99 USD after the discount period
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... or other trends? You're in the right place! Check StockTreats features.